How to Pick Low Hanging Glaucoma Fruit
In an era of improved technologies, it has never been easier – or more affordable – to identify undiagnosed glaucoma patients
Jonathan Myers | | Opinion
Doctors generally go to work wanting to make a difference. Fortunately, there has never been a better time for our patients with glaucoma – there are an ever-increasing number of advanced technology and treatment options. Not only do the latest OCT machines reveal incredible details of the retinal nerve fiber layer and macular ganglion cell layer, we also have the ability to measure corneal hysteresis and corneal thickness, helping further reduce a person’s risk of glaucoma progression.
Recent research promises quantification of apoptosis in retinal ganglion cells in vivo, while new classes of drugs and novel approaches to surgery allow more customized approaches for individual patients. These tremendous advances mean we can offer better care to our patients with glaucoma and they may even allow us to reduce the patients’ risk of vision loss and burden of treatment. However, studies suggest that a large portion of people with glaucoma – perhaps half – are undiagnosed and, as a result, untreated.
Read the full article now
Log in or register to read this article in full and gain access to The Ophthalmologist’s entire content archive. It’s FREE!
Or register now - it’s free!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Ophthalmologist magazine